Loading…
Parathyroid Disorders of Pregnancy
Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism...
Saved in:
Published in: | Seminars in perinatology 1998-12, Vol.22 (6), p.485-496 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323 |
---|---|
cites | cdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323 |
container_end_page | 496 |
container_issue | 6 |
container_start_page | 485 |
container_title | Seminars in perinatology |
container_volume | 22 |
creator | Mestman, Jorge H. |
description | Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies. |
doi_str_mv | 10.1016/S0146-0005(98)80028-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69121926</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0146000598800281</els_id><sourcerecordid>69121926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</originalsourceid><addsrcrecordid>eNqFkM1LAzEQxYMotVb_hELxIHpYndkku8lJpH5CwYIK3kI2Hxppd2uyFfrfu7WlV08D896b4f0IGSJcImBx9QLIigwA-LkUFwIgFxnukT5yLjIo-fs-6e8sh-QopS8AyiRCj_SkEIAo-uR0qqNuP1exCXZ0G1ITrYtp1PjRNLqPWtdmdUwOvJ4ld7KdA_J2f_c6fswmzw9P45tJZmgBbeZ1XpXGWQPUMa5txbxlnDGwYI3mFcoSCtSMo_dyvaG8lOhpaRgtJM3pgJxt7i5i8710qVXzkIybzXTtmmVShcQcZV50Rr4xmtikFJ1XixjmOq4UglqzUX9s1Lq4kkL9sVHY5YbbB8tq7uwutYXR6dcb3XUtf4KLKpng6q5TiM60yjbhnw-_3QJyPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69121926</pqid></control><display><type>article</type><title>Parathyroid Disorders of Pregnancy</title><source>ScienceDirect Freedom Collection</source><creator>Mestman, Jorge H.</creator><creatorcontrib>Mestman, Jorge H.</creatorcontrib><description>Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies.</description><identifier>ISSN: 0146-0005</identifier><identifier>EISSN: 1558-075X</identifier><identifier>DOI: 10.1016/S0146-0005(98)80028-1</identifier><identifier>PMID: 9880118</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Female ; Humans ; Hypercalcemia - etiology ; Hyperparathyroidism - complications ; Hyperparathyroidism - therapy ; Hypoparathyroidism ; Osteoporosis ; Parathyroid Diseases ; Pregnancy ; Pregnancy Complications ; Pseudohypoparathyroidism</subject><ispartof>Seminars in perinatology, 1998-12, Vol.22 (6), p.485-496</ispartof><rights>1998 W.B. Saunders Company. All rights reserved</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</citedby><cites>FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9880118$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mestman, Jorge H.</creatorcontrib><title>Parathyroid Disorders of Pregnancy</title><title>Seminars in perinatology</title><addtitle>Semin Perinatol</addtitle><description>Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies.</description><subject>Female</subject><subject>Humans</subject><subject>Hypercalcemia - etiology</subject><subject>Hyperparathyroidism - complications</subject><subject>Hyperparathyroidism - therapy</subject><subject>Hypoparathyroidism</subject><subject>Osteoporosis</subject><subject>Parathyroid Diseases</subject><subject>Pregnancy</subject><subject>Pregnancy Complications</subject><subject>Pseudohypoparathyroidism</subject><issn>0146-0005</issn><issn>1558-075X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkM1LAzEQxYMotVb_hELxIHpYndkku8lJpH5CwYIK3kI2Hxppd2uyFfrfu7WlV08D896b4f0IGSJcImBx9QLIigwA-LkUFwIgFxnukT5yLjIo-fs-6e8sh-QopS8AyiRCj_SkEIAo-uR0qqNuP1exCXZ0G1ITrYtp1PjRNLqPWtdmdUwOvJ4ld7KdA_J2f_c6fswmzw9P45tJZmgBbeZ1XpXGWQPUMa5txbxlnDGwYI3mFcoSCtSMo_dyvaG8lOhpaRgtJM3pgJxt7i5i8710qVXzkIybzXTtmmVShcQcZV50Rr4xmtikFJ1XixjmOq4UglqzUX9s1Lq4kkL9sVHY5YbbB8tq7uwutYXR6dcb3XUtf4KLKpng6q5TiM60yjbhnw-_3QJyPw</recordid><startdate>19981201</startdate><enddate>19981201</enddate><creator>Mestman, Jorge H.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19981201</creationdate><title>Parathyroid Disorders of Pregnancy</title><author>Mestman, Jorge H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Female</topic><topic>Humans</topic><topic>Hypercalcemia - etiology</topic><topic>Hyperparathyroidism - complications</topic><topic>Hyperparathyroidism - therapy</topic><topic>Hypoparathyroidism</topic><topic>Osteoporosis</topic><topic>Parathyroid Diseases</topic><topic>Pregnancy</topic><topic>Pregnancy Complications</topic><topic>Pseudohypoparathyroidism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mestman, Jorge H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in perinatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mestman, Jorge H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parathyroid Disorders of Pregnancy</atitle><jtitle>Seminars in perinatology</jtitle><addtitle>Semin Perinatol</addtitle><date>1998-12-01</date><risdate>1998</risdate><volume>22</volume><issue>6</issue><spage>485</spage><epage>496</epage><pages>485-496</pages><issn>0146-0005</issn><eissn>1558-075X</eissn><abstract>Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>9880118</pmid><doi>10.1016/S0146-0005(98)80028-1</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0146-0005 |
ispartof | Seminars in perinatology, 1998-12, Vol.22 (6), p.485-496 |
issn | 0146-0005 1558-075X |
language | eng |
recordid | cdi_proquest_miscellaneous_69121926 |
source | ScienceDirect Freedom Collection |
subjects | Female Humans Hypercalcemia - etiology Hyperparathyroidism - complications Hyperparathyroidism - therapy Hypoparathyroidism Osteoporosis Parathyroid Diseases Pregnancy Pregnancy Complications Pseudohypoparathyroidism |
title | Parathyroid Disorders of Pregnancy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T03%3A41%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parathyroid%20Disorders%20of%20Pregnancy&rft.jtitle=Seminars%20in%20perinatology&rft.au=Mestman,%20Jorge%20H.&rft.date=1998-12-01&rft.volume=22&rft.issue=6&rft.spage=485&rft.epage=496&rft.pages=485-496&rft.issn=0146-0005&rft.eissn=1558-075X&rft_id=info:doi/10.1016/S0146-0005(98)80028-1&rft_dat=%3Cproquest_cross%3E69121926%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69121926&rft_id=info:pmid/9880118&rfr_iscdi=true |